Role of placebo in irritable bowel syndrome

Journal of Pediatric Gastroenterology and Nutrition

Volumn 53, Issue SUPPL. 2, 2011, Pages

  Kirsch, Irving ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO;

ACUPUNCTURE; ATTENTION; DOCTOR PATIENT RELATION; HOSPITAL ADMISSION; HUMAN; IRRITABLE COLON; PLACEBO EFFECT; PRIORITY JOURNAL; SHORT SURVEY; THERAPY EFFECT; TIME; TREATMENT OUTCOME;

ACUPUNCTURE THERAPY; ADMINISTRATION, ORAL; HUMANS; IRRITABLE BOWEL SYNDROME; PLACEBOS;

EID: 82355170475     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (6)

1. Patel SM, Stason WB, Legedza A, et al. The placebo effect in irritable bowel syndrome trials: a meta-analysis. Neurogastroenterol Motil 2005;17:332-40. (Pubitemid 40768905)
2. Rahimi R, Nikfar S, Abdollahi M. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: A meta-analysis of eight randomized, placebo-controlled, 12-week trials. Clin Ther 2008;30:884-901. (Pubitemid 351802282)
3. Hróbjartsson A, Norup M. The Use of Placebo Interventions in Medical Practice-A National Questionnaire Survey of Danish Clinicians. Eval Health Prof 2003;26:153-65. (Pubitemid 36583430)
4. Tilburt JC, Emanuel EJ, Kaptchuk TJ, et al. Prescribing "placebo treatments": results of national survey of US internists and rheumatol-ogists. BMJ 2008;337:1097-100.
5. Kaptchuk TJ, Kelley JM, Conboy LA, et al. Components of the Placebo Effect: A randomized controlled trial in irritable bowel syndrome. BMJ 2008;336:998-1003.
6. Benedetti F, Maggi G, Lopiano L, et al. Open versus hidden medical treatments: The patient's knowledge about a therapy affects the therapy outcome. Prev Treat 2003;6:1a.